Biopharma research is an important source of jobs, tax revenue and research spending in SC see more
New findings show biopharma research companies a source of jobs, tax revenue and research spending in state
GREENVILLE, S.C., October 4, 2018 – This week, the Pharmaceutical Research and Manufacturers of America (PhRMA) released a new report that finds there are more than 572 active clinical trials in the South Carolina, and the life science industry supports 29,500 high-quality jobs and contributes $7.9 billion to South Carolina’s economy. These clinical trials can be responsible for more than half of the $2.6 billion average cost of developing one new medicine. They are investigating some of the biggest health care challenges South Carolinians face, including arthritis, cancer, diabetes, cardiovascular disease, and Alzheimer’s disease.
The report, titled “Research in Your Backyard: Developing Cures, Creating Jobs, Pharmaceutical Clinical Trials in South Carolina,” was released at a press event held at the Westin Poinsett today, which featured a panel discussion including researchers and executives from the Greenville Health System, KIYATEC, the Hollings Cancer Center at MUSC, and the Greenwood Genetic Center, moderated by SCBIO President and CEO, Sam Konduros.
“Clinical trials offer patients novel medical treatments right here in the Palmetto State, while also allowing biopharma research organizations to innovate and grow,” said Konduros. “Across South Carolina, the life sciences and healthcare industries have had a profound impact on our economy and citizens, that continues to rapidly increase.”
Clinical trials are a vital component of bringing new life-saving drugs and treatments to market. On average, it takes approximately a decade for new medicines to go through the rigorous Food and Drug Administration (FDA) approval process. Only 12 percent of drugs successfully make it through clinical trials. Since 2004, biopharmaceutical research companies have conducted or are currently conducting more than 4,700 clinical trials in South Carolina. In 2013 alone, the nearly 1,100 active clinical trials in the state generated an estimated economic impact of $540 million.
“One of the most important things we want people to understand about medicine development is that clinical trials rely on patient participation,” said Nick McGee, Director of Public Affairs for PhRMA. “It’s incredibly important that patients are aware of ongoing trials and learn how they can help become part of finding a cure for the toughest chronic conditions and diseases we face today.”
In the United States, there are more than 7,000 open clinical trials being sponsored by the biopharmaceutical industry, universities, individuals and organizations combined. In South Carolina, of the 572 open clinical trials involving the biopharmaceutical research industry, the University of South Carolina Medial School is collaborating on more than 143 clinical trials and the Medical University of South Carolina is collaborating on more than 142.
“Many top research and medical universities call South Carolina home and are centers of innovation,” Bob Quinn, Executive Director of the South Carolina Research Authority, said. “Maintaining strong partnerships between our universities and life science companies allows us to foster developments right here in South Carolina that can then help save lives far beyond our state lines.”
The Pharmaceutical Research and Manufacturers of America (PhRMA) represents the country’s leading innovative biopharmaceutical research companies, which are devoted to discovering and developing medicines that enable patients to live longer, healthier, and more productive lives. Since 2000, PhRMA member companies have invested more than $600 billion in the search for new treatments and cures, including an estimated $71.4 billion in 2017 alone.
About SC BIO
SCBIO is South Carolina’s investor-driven public/private economic development organization focused on building, advancing, and growing the life sciences industry in the state. With an $11.4 billion annual economic impact in the Palmetto State, with more than 400 firms and 15,000 professionals directly involved in the research, development and commercialization of innovative healthcare, medical device, industrial, environmental and agricultural biotech and products that make a difference across the Palmetto State and around the world. Visit us at SCBIO.org.
Grant to fund creation of the South Carolina Medical Device Alliance to invent and develop products see more
SCRA has been awarded approximately $750,000 in federal grant funding by the U.S. Economic Development Administration (EDA) as part of the 2018 Regional Innovation Strategies Competition. The grant will fund the creation of the South Carolina Medical Device Alliance to invent and develop products and bring them to market. This partnership, comprised of Clemson University, the Medical University of South Carolina and industry leaders, will form a regional innovation cluster to grow the economic impact of the medical device industry through job creation and startup formation, as well as to attract international businesses to establish a presence in South Carolina. The project total is $1,814,846, which includes the federal grant funding and matching funds.
“We are honored to be one of forty recipients nationwide,” said Christine Dixon Thiesing, SCRA’s Director of Academic Programs. “This program will serve South Carolina’s academic institutions and clinical innovators to overcome challenges inherent in the commercialization of medical devices. Building the medical device sector will also diversify South Carolina’s economy strategically by leveraging the existing skilled workforce and fostering a broader range of job opportunities for its workers.”
The Office of Innovation and Entrepreneurship, housed within the U.S. Department of Commerce’s Economic Development Administration, leads the Regional Innovation Strategies Program to spur innovation capacity-building activities in regions across the nation.
“MUSC’s Foundation for Research Development (FRD) is excited to be partnering with SCRA on this project,” said Michael Rusnak, Executive Director of FRD. “This gives MUSC one more vehicle to advance medical device technologies through our company startup activities; a substantial win for local economic development and more importantly, patients.”
To learn more about the South Carolina Medical Device Alliance, including the scope of work and key personnel click here.
SCRA is a state-chartered organization that fuels South Carolina’s innovation economy by accelerating technology-enabled growth in research, academia, entrepreneurship and industry.
22 WESTEDGE BREAKS GROUND AND BREAKS THE MOLD FOR INNOVATIVE LIFE SCIENCES WORKPLACES IN CHARLESTON, SCNEW LIFE SCIENCES DISTRICT KICKS OFF CONSTRUCTION IN CHARLESTON, SC AT WESTEDGE see more
Charleston, SC - July 17, 2018 marked the construction kickoff for 22 WestEdge, a striking new workplace anchor for the city’s growing knowledge economy and the highly anticipated centerpiece of the WestEdge District. The iconic 125-foot, eight-story structure will be the tallest multi-tenant office building on the peninsula and in Charleston’s metropolitan area when it opens in November 2019.
“22 WestEdge affirms the vision for a Live, Learn and Earn district, adding vital office, research and lab components to the world class WestEdge community. It builds on the remarkable momentum of a development that already has over $300 million under construction,” said Michael Maher, CEO of The WestEdge Foundation, Inc., the non-profit sponsor of the overall development.
Even prior to the 22 WestEdge groundbreaking, area economic development proponents including The Medical University of South Carolina, the South Carolina Research Authority, the City of Charleston, Heritage Trust and the WestEdge Foundation committed to 22 WestEdge, forming the nucleus of entities working to incubate, attract and retain entrepreneurial talent to energize the Charleston economy. While 48% of the space is currently leased, 72,000 square feet of office space and 10,000 square feet of retail space remain available for existing local businesses, or for new companies being created or relocating to the Charleston region. This is a remarkable concentration of ingenuity¾over 35,000 people live, work, study and seek healthcare expertise in the adjacent medical district.
Partnership and innovation opportunities abound for 22 WestEdge tenants—with unprecedented access to like-minded neighbors and colleagues in Charleston’s life sciences sector. Dr. David Cole, President of MUSC shared, “With MUSC’s $275 million of research and proprietary discoveries, 22 WestEdge will allow the University to collaborate with private industry to create new healthcare solutions, new companies and recruit existing global medical-related companies to Charleston.” Bob Quinn, Executive Director of the SCRA agreed, “SCRA’s leasing of the entire top floor of 22 WestEdge will allow us to create a world-class facility, including laboratories, which will serve as a catalyst for the attraction of leading life sciences companies and the creation of a Discovery District adjacent to MUSC.”
Charleston Mayor John Tecklenburg echoed, “It’s no secret that biomedical advances will be a key driver of our economy and society in the years ahead. With 156,000 square feet of office space dedicated to precisely the kind of research and enterprise that will help make those breakthroughs possible, 22 WestEdge is a welcome and important addition to our city’s medical district.”
22 WestEdge office tenants will also benefit from the energy and vitality of the district. Recently completed, The Caroline has 237 apartments and 20,000 square feet of retail and restaurant space, and the topped-out 10 WestEdge will have 350 residential units, a Publix Super Market, Woodhouse Spa and additional retail and restaurant space, providing an abundance of shopping, eating and living options for all. 22 WestEdge’s own amenities include 15,000 square feet of cafes and fitness facilities, common conference and event facilities and a terrace wrapping the 7th floor with sweeping views of the Ashley River. Mack Reese, 22 WestEdge developer and partner, explains his reason for developing the project, “With its access to parking, numerous retail amenities and an urban density of residential opportunities for employees, the building will be a new and exciting option for existing Charleston businesses and those looking to relocate to the region.”
Upon completion, WestEdge’s master-planned mixed-use district will encompass more than 3,000,000 square feet of space on 60 acres along the Ashley River adjacent to MUSC and the Medical District, and fronting on Brittlebank Park and the Joseph Riley Baseball Stadium. WestEdge is a public-private partnership created to advance economic development and expand the research capabilities of the Medical University of South Carolina and foster new companies and collaborative opportunities with private industry. It is an innovative redevelopment that is transforming the quality of life for Charleston’s west side.
Key 22 WestEdge partners include Gateway Development (Developer) ELV Associates (Investor), BB&T (Lender), Trident Construction (General Contractor), Perkins & Will (Architect), Thomas and Hutton (Civil Engineer), and Lee & Associates (Marketing & Leasing).
For leasing inquiries and further detail on WestEdge development, please contact Mack Reese of Gateway Development (770-310-3414 ).
South Carolina's life sciences industry is booming. Read on for details... see more
From pharmaceuticals and medical devices to research and laboratory testing, the state's life sciences field is booming. The Charleston and Lowcountry region is home to many established companies and start-ups making a mark on the biomedical and health industries. Read on for the full story from Charleston Business Magazine's 2018 State of the Lowcountry Report.
SCRA Collaboration Center Awards feature numerous life science organizations from across the state. see more
South Carolina Research Authority’s SCRA-Academia Collaboration Team announces nearly $600,000 in feasibility grants for six projects. The awarded projects encourage collaboration between academic institutions and industry partners to advance commercially relevant research and establish the feasibility of the formation of Collaboration Centers. These Collaboration Centers will be founded for those areas demonstrating a critical mass of talent, infrastructure, financial resources, intellectual property and the prevalence of industry in South Carolina.
“These Feasibility Grants are the first step in establishing Collaboration Centers, which will garner national recognition for South Carolina, create jobs, engage industry and have an overall positive impact on the state.” said Christine Dixon Thiesing, Director of Academic Programs. “SCRA is fostering the growth of collaboration across academic institutions and between academia and industry through the support of six innovation projects.”
The Feasibility Grant Awards are the result of the efforts of the SACT, which was formed to deliver outcomes aligned with the Strategic Collaboration Agreement signed by SCRA and the presidents of the state’s research universities. The SACT is composed of representatives from the research universities, comprehensive teaching institutions, technical colleges, industry and SCRA. The SACT is currently evaluating the feasibility of establishing three Collaboration Centers – a Composites Industry Solutions Center, Medical Devices Collaboration Center, and Technology-Enabled Population Health Collaboration Center.
The list of grant awardees is below:
Composites Industry Solutions Center:
Collaboration among Clemson University, Greenville Technical College and industry partners Kistler Instrument Corp., Keyence Corporation of America and Renishaw.
Medical Devices Collaboration Center:
Collaboration between the Medical University of South Carolina and Clemson University.
Technology-Enabled Population Health Collaboration Center:
Collaboration among the Medical University of South Carolina, Trident Technical College and industry partners Zeriscope, Inc. and Amanda Senior Care.
Collaboration between Francis Marion University and a regional health organization as the industry partner.
Collaboration among University of South Carolina – Upstate and industry partners ChartSpan Medical Technologies and a state agency.
Collaboration among Clemson University, Florence-Darlington Technical College’s Southeastern Institute of Manufacturing and Technology and industry partner Greenville Health System.
SCRA, SBA form Strategic Alliance to further economic development, innovation see more
The U.S. Small Business Administration’s S.C. District has partnered with SCRA to form a Strategic Alliance Memorandum.
The alliance is expected to further economic development through entrepreneurship, educational opportunities and access to capital and technical assistance.
“We recognize the common goals of SCRA and SBA in helping start, maintain and expand small businesses,” R. Gregg White, S.C. SBA district director, said in a statement. “This is an opportunity to leverage the resources of both organizations for the benefit of South Carolina small businesses.”
Bob Quinn, SCRA’s executive director, joined White in signing the memorandum at the Applied Technologies Center in Summerville.
“By supporting entrepreneurs, small businesses and early-stage companies, we are creating opportunities for the citizens of South Carolina,” Quinn said. “We are excited to formalize our relationship with the S.C. SBA and look forward to our future collaborations with their team.”
SCRA, chartered in 1983, is a public nonprofit that supports entrepreneurs and academic research and connects industry to innovators.
Dr. Denise Hines, Joe Lee, Other Top National Speakers Named for SEMDA’s 2018 Southeastern Medtech Conference in Greenville, SCSEMDA Medtech 2018 is coming to Greenville, SC May 2-4. see more
Conference Registration Surging for Initial Appearance in Greenville, SC as Southeastern medtech industry continues rapid scale up
Greenville, SC – April 17, 2018 -- The Southeastern Medical Device Association (SEMDA) -- a non-profit trade association focused on making the Southeast a world-class region for medical technology, device, and diagnostic companies – has announced an initial group of featured speakers for the 2018 SEMDA Medtech Conference May 2-4, 2018.
For the first time ever, the annual Southeastern showcase of who’s who and what is happening in medtech will convene in South Carolina, with the Hyatt Regency Greenville serving as headquarters hotel.
Among the featured speakers announced today that have committed to present at the conference are Joe Lee, Executive Director of Life Sciences for JP Morgan; Andy Fish, Chief Strategy Officer of AdvaMed; and Denise Hines, North American Chair of the Health Information & Management Systems Society and current CEO of eHealth Services Group. Also speaking will be Lee Burnes, Vice President of Global Research & Development at Halyard Health; and Jim Stefansic, Chief Executive Officer of Raiven Healthcare.
Additional featured speakers are expected to be named shortly, and companies engaged in presenting to industry executives in the PitchRounds program, co-sponsored by SCRA, SCBIO and Eversheds Sutherland, will be announced within the week. PitchRounds is a highly targeted event for both start-ups and “Seed” companies as well as later-stage (Series A or later) organizations to present ideas, innovations and products to panels of institutional investors, regulatory leaders, venture capital directors, IP experts and others in structured sessions. Selected participants receive individual feedback on their presentations and compete for $10,000 in top prize money.
“The South Carolina medtech industry has been a strong supporter of SEMDA for many years and is growing at one of the fastest rates in the country, so we are excited to tap into the growth and excitement in the industry by bringing this preeminent event to the Palmetto State for the first time,” said Jason Rupp, Executive Director of SEMDA. “Most importantly, we are thrilled to unveil members of a stellar group of industry experts who will be presenting to members drawn from across the Southeastern United States and to industry attendees from across North America.”
The SEMDA conference typically attracts more than 400 executives in medtech and life sciences from throughout the United States and has become a must-attend for the medtech community. Registration is currently surging, noted Mr. Rupp, and a full house of medtech industry leaders is again expected. Persons interested in attending can review the agenda, speakers and registration details online at http://www.semda.net.
Joe Lee, who will keynote Day 2 of the conference, is Executive Director of Life Sciences for JP Morgan and leads the Middle Market Banking coverage of life science companies across the Southeast. Well-known and respected in life science industry circles, Mr. Lee will discuss key opportunity areas for growth in the Southeast and provide rapid-growth companies with counsel on how to prepare their organizations for success in the competitive space.
Andrew Fish is Chief Strategy Officer of AdvaMed, the leading trade association advancing medical technology in the U.S. and around the world. As chief strategy officer, Mr. Fish leads the association’s strategic planning, oversees AdvaMed's global, regulatory, and payment departments, and coordinates the development and operations of AdvaMed’s membership divisions and sectors.
Dr. Denise Hines is current Chair of the North America Board of the Health Information & Management Systems Society (HIMSS), and is actively involved in HIMSS’ Women in Health IT initiatives that promote diversity and recognition. She is CEO of eHealth Services Group and serves as Executive Director of Georgia’s statewide health information exchange (HIE).
Lee Burnes is Vice President of Global R&D for Halyard Health where the organization is focused on development of products, technologies and solutions that prevent infection, eliminate pain and speed recovery. Prior to joining Halyard, Lee successfully led numerous R&D organizations at Covidien.
Jim Stefansic serves as President and CEO of Raiven Healthcare, a provider of healthcare artificial intelligence and data analytics solutions. An accomplished entrepreneur, Jim has years of experience launching and growing numerous healthcare technology businesses. He previously was co-founder and COO of Pathfinder Therapeutics, Inc., where he helped bring industry-leading image-guided surgical products to market.
“These presenters and others we will announce shortly demonstrates that SEMDA has evolved into a truly regional organization that embraces and represents the collective of medtech startups, universities, corporate organizations, investment resources and capabilities across the southeastern United States,” Mr. Rupp said. “The conference provides a great opportunity to interact with other companies, investors, customers, partners, and specialized service providers.”
# # #
The Southeastern Medical Device Association (SEMDA) is a regional non-profit trade association that supports and promotes medical device and medical device data system (MDDS) companies in the Southeast. Created in 2004, the association provides unique educational resources to accelerate device development and achieve commercial success with access to funding, education, and networking opportunities for medical device companies, inventors, physicians, investors, tech transfer offices, universities, sponsors, and service providers interested in growing the medical device industry in the Southeast.
S.C.-based Global Transplant Solutions received investment see more
The South Carolina Research Authority’s S.C. Launch program has finalized a $200,000 investment for Global Transplant Solutions, a Duncan-based company that develops and distributes products for the human organ procurement and transplant marketplace.
The investment will be used to finalize global sales, develop proprietary products, and further the company’s research efforts, according to a news release.
“We are proud to partner with SC Launch and the state of South Carolina as we establish, build, and grow our worldwide organ transplant business,” said John Bruens, CEO of Global Transplant Solutions. “As a company exclusively focused on supporting the critical need for more donated organs and partnering with the dedicated professionals in this market who every day save countless lives around the world, Global Transplant Solutions Inc. is poised to position South Carolina as the epicenter for the advancement of transplant technologies, products, and policies.”
Global Transplant Solutions currently supplies products to the Canadian transplant market. The company has received clearance from the U.S. Food and Drug Administration (FDA) to distribute its first product in the United States and is awaiting FDA clearance for a second product.
The company also plans to gain clearance from the FDA for four additional products, which together will represent 99 percent of all organ preservation solutions used worldwide. It already has distribution agreements with several national and international partners, according to a news release.
“There is a worldwide demand for Global Transplant Solutions’ products, and to see the demand being fulfilled by a company in Duncan, S.C., is very exciting,” said Jill Sorensen, director of entrepreneurial programs at the South Carolina Research Authority (SCRA).
The SCRA is a state-chartered organization that fosters job creation and grows the innovation economy. The S.C. Launch program is the authority’s entrepreneurial platform that provides mentoring, grants, and investments to qualified companies in the advanced materials, information technology, and life sciences industries.
For more information, visit scra.org.
Accessible Diagnostics receives $250,000 SC Launch Investment see more
March 15, 2018 11:50 AM Eastern Daylight Time
SUMMERVILLE, S.C.--(BUSINESS WIRE)--SC Launch, Inc., SCRA’s entrepreneurial program, recently finalized a $250,000 investment for Accessible Diagnostics, a life science company based in Greenville, SC. The company was accepted as an SC Launch Client Company in December 2014 and received a $50,000 Acceleration Grant in June 2017.
Accessible Diagnostics is developing a smartphone-based, at-home health test platform in collaboration with healthcare professionals. Their first proprietary product, Vet-Tab, is a painless glucose test for a beloved family member, a diabetic dog. The investment will be used to finalize product development, manufacture the initial inventory and launch sales. The company has also begun the regulatory process to sell painless human glucose test.
“Concepts to Companies and accredited individuals provided the seed capital for Accessible Diagnostics to startup and reach this point,” said John Warner, Accessible Diagnostics CEO and Co-Founder. “We are grateful for Acceleration Grant last summer to help with prototype development and their investment this spring to help launch Vet-Tab sales.”
“Accessible Diagnostics can create enormous value by aggregating data to integrate into other digital heath platforms being created in the market,” said Director of Entrepreneurial Programs and SC Launch Inc. Executive Director, Jill Sorenson. “We are excited to see the growth of the company and the impact to South Carolina.”
SCRA is a state-chartered organization that fosters job creation and grows South Carolina’s Innovation Economy. The SC Launch program is SCRA’s entrepreneurial platform that provides mentoring, grants and investments to qualified, South Carolina companies in the Advanced Materials/Manufacturing, Information Technology and Life Sciences industries.
Chartered in 1983 by the State of South Carolina as a public, non-profit corporation, SCRA fosters South Carolina's Innovation Economy by supporting entrepreneurs, enabling academic research and its commercialization, and connecting industry to innovators.
Jessica Cokins, 843-760-3273
Jill Sorensen has joined SCRA to lead SC Launch, entrepreneurial programs see more
Summerville, S.C. – SCRA, a public, non-profit chartered with fostering the Innovation Economy of South Carolina, has announced the appointment of Jill Sorensen, J.D. as the new Director of Entrepreneurial Programs and Executive Director of SC Launch. Jill is an innovation manager with more than twenty-five years of experience in emerging technology, intellectual asset management and economic development.
In her new role, Jill will oversee the direction of SCRA’s entrepreneurial programs, under which provides investments, grant opportunities, mentoring and support to early-stage technology companies in the Life Science, IT and Advanced Manufacturing/Materials industries.
Jill is assuming this role upon the retirement of Greg Hillman, who worked in SCRA’s SC Launch program for more than ten years, during which time the program provided grants and investments to more than 330 companies. During Greg’s time with the company, SC Launch Portfolio Companies secured more than $650 million of external capital.
Prior to joining SCRA, Jill directed an innovation management consultancy that advised startups across the health, energy, transportation and manufacturing sectors. Jill co-founded and directed the Baltimore-Washington Electric Vehicle Initiative, a division of the non-profit Electric Vehicle Association of the Greater Washington DC area. Additionally, she served as Executive Director of the Johns Hopkins University Technology Transfer Office and taught innovation management at the university. Before joining Johns Hopkins, Jill worked for the University of Illinois directing its Office of Technology Management and serving as in-house intellectual property counsel. Jill is a registered patent attorney, earned her J.D. from DePaul University and her B.A. from Northwestern University.
“Jill’s diverse experience makes her uniquely qualified for this position,” said SCRA Executive Director Bob Quinn. “Her skill sets will benefit each aspect of the role, and we are excited she has joined the team.”
Chartered in 1983 by the State of South Carolina as a public, non-profit corporation, SCRA fosters South Carolina's Innovation Economy by supporting entrepreneurs, enabling academic research and its commercialization, and connecting industry to innovators.
Eight story office and lab building named 22 WestEdge breaks ground in Charleston, SC see more
The third multistory building set to rise in the developing WestEdge community on the Charleston peninsula broke ground Thursday — under a tent because of all the recent rain.
The eight-story office and laboratory structure called 22 WestEdge will sit next to the under-construction, nine-story 10 WestEdge building at Spring Street and Lockwood Drive. That’s where Publix supermarket is set to open on the ground floor in October.
The first floor of the all-glass exterior structure will house 15,750 square feet of retail space while the upper floors will provide 138,500 square feet of office space-targeted firms in the so-called knowledge economy, such as the life sciences industry. About half of the site has already been leased.